30 Day Trial

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Quarterly Review

3Q12 Earnings: aap Implantate

€8.6MM (~US $10.9MM), +25% (Trauma +46%; Biomaterials +7%; Gels/Fluids/Bone Material Contract Manufacture +>100%)

  • Received FDA clearance for LOQTEQ plating systems, expecting clearance of entire product family in 4Q
  • Developing 6 additional LOQTEQ systems
  • Appointed new distributors in 6 geographic markets
  • Received approval under the CE Mark for new bone cement